The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice

The influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (±)-[2-[4-(3-ethoxy–2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized by...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazuhito Asano, Tetsuya Mizutani, Toshikazu Shimane, Masataka Hisano, Tadashi Hisamitsu, Harumi Suzaki
Format: Article
Language:English
Published: Wiley 2000-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1080/096293500411532
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565208112955392
author Kazuhito Asano
Tetsuya Mizutani
Toshikazu Shimane
Masataka Hisano
Tadashi Hisamitsu
Harumi Suzaki
author_facet Kazuhito Asano
Tetsuya Mizutani
Toshikazu Shimane
Masataka Hisano
Tadashi Hisamitsu
Harumi Suzaki
author_sort Kazuhito Asano
collection DOAJ
description The influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (±)-[2-[4-(3-ethoxy–2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized by intraperitoneal injection of dinitrophenylated-keyhole limpet hemocyanin (DNP-KLH) mixed with Al(OH)3 (DNP-KLH). IPD-1151T was administered orally once a day for either 5 or 14 days in doses of 10, 30 or 100 mg/kg. Bronchoconstriction was measured 24 h after the final drug administration. IPD-1151T inhibited both antigen- and MCh-mediated bronchoconstriction in actively sensitized mice. The inhibition induced was closely related to the dose and frequency of oral administration of the agent. We also examined the effect of IPD-1151T on IgE production in response to DNP-KLH immunization. IPD-1151T inhibited dose-dependently both total and specific IgE concentrations in serum prepared from mice 15 days after im munization. These results strongly indicate that IPD-1151T inhibits IgE production in vivo and results in attenuating effect on bronchoconstriction.
format Article
id doaj-art-ed8bd14e565a4eee9d91de52ef6cf6ea
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2000-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-ed8bd14e565a4eee9d91de52ef6cf6ea2025-02-03T01:09:03ZengWileyMediators of Inflammation0962-93511466-18612000-01-0192778410.1080/096293500411532The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized miceKazuhito Asano0Tetsuya Mizutani1Toshikazu Shimane2Masataka Hisano3Tadashi Hisamitsu4Harumi Suzaki5Department of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Shinagawa-ku, Tokyo 142–8555, JapanThe influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (±)-[2-[4-(3-ethoxy–2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized by intraperitoneal injection of dinitrophenylated-keyhole limpet hemocyanin (DNP-KLH) mixed with Al(OH)3 (DNP-KLH). IPD-1151T was administered orally once a day for either 5 or 14 days in doses of 10, 30 or 100 mg/kg. Bronchoconstriction was measured 24 h after the final drug administration. IPD-1151T inhibited both antigen- and MCh-mediated bronchoconstriction in actively sensitized mice. The inhibition induced was closely related to the dose and frequency of oral administration of the agent. We also examined the effect of IPD-1151T on IgE production in response to DNP-KLH immunization. IPD-1151T inhibited dose-dependently both total and specific IgE concentrations in serum prepared from mice 15 days after im munization. These results strongly indicate that IPD-1151T inhibits IgE production in vivo and results in attenuating effect on bronchoconstriction.http://dx.doi.org/10.1080/096293500411532
spellingShingle Kazuhito Asano
Tetsuya Mizutani
Toshikazu Shimane
Masataka Hisano
Tadashi Hisamitsu
Harumi Suzaki
The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice
Mediators of Inflammation
title The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice
title_full The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice
title_fullStr The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice
title_full_unstemmed The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice
title_short The inhibitory effect of anti-allergic agent suplatast tosilate (IPD–1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice
title_sort inhibitory effect of anti allergic agent suplatast tosilate ipd 1151t on methacholine and allergen induced bronchoconstriction in sensitized mice
url http://dx.doi.org/10.1080/096293500411532
work_keys_str_mv AT kazuhitoasano theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT tetsuyamizutani theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT toshikazushimane theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT masatakahisano theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT tadashihisamitsu theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT harumisuzaki theinhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT kazuhitoasano inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT tetsuyamizutani inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT toshikazushimane inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT masatakahisano inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT tadashihisamitsu inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice
AT harumisuzaki inhibitoryeffectofantiallergicagentsuplatasttosilateipd1151tonmethacholineandallergeninducedbronchoconstrictioninsensitizedmice